 |
Busulfan |
|---|---|
| Trade Name | Spartaject |
| Orphan Indication | For use as preparative therapy for malignancies treated with bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1994-04-21 00:00:00 |
| Sponsor | Sparta Pharmaceuticals, Inc.;111 Rock Road;Horsham, Pennsylvania, 19044 |
